Healthcare Global Enterprises Share Price

NSE: HCG

₹ 666.55

-₹3.35 (-0.5%)

Last updated 24 Jul, 2026, 15:40 IST

Healthcare Global Enterprises Share Price Today

As of 25 Jul 2026, Healthcare Global Enterprises share price is ₹666.55. The stock opened at ₹674.80, compared to its previous close of ₹669.90. During today's trading session, Healthcare Global Enterprises share price moved in the range of ₹660.65 to ₹675.00, with an average price of ₹667.83 for the day. Looking at its last 52-week, the stock has touched a low of ₹513.30 and a high of ₹804.65. On the performance front, Healthcare Global Enterprises share price has increased by 7.79% over the last six months and is up 18.73% on a year-on-year basis.

₹660.65

0.50% down today

₹675.00

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 120.59% QoQ

Latest Earning

Net Profit TrendUp by 151.14% QoQ

Latest Earning

Revenue TrendUp by 4.70% QoQ

Stock Performance

OutperformingBeat Nifty by 9.48 % in last 1 month

Shareholding Pattern

DIIDII increased stake by 4.86%

Shareholding Pattern

FIIFII decreased stake by 0.51%

Healthcare Global Enterprises Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹5,84,693+₹84,693 (+16.94%)

3 Year

₹10,29,580+₹5,29,580 (+105.92%)

5 Year

—

₹535.95₹803.85

Circuit Low

Circuit High

₹513.30₹804.65

52-Week Low

52-Week High

Circuit

₹535.95

₹803.85

52-week

₹513.30

₹804.65

Mkt Cap Cr

9,992.80

P/E

435.46

P/B

7.47

ROE

2.90%

D/E

0.64

ROCE

7.81%

Div. Yield

0.00%

EPS(TTM)

1.03

Turnover

0.57

EV/EBITDA

25.01

Net Margin

0.00%

Op. Margin

0.00%

ROA

0.58%

Quick Ratio

0.00

Curr. Ratio

3.66

Mkt Cap Cr

9,992.80

P/E

435.46

P/B

7.47

ROE

2.90%

D/E

0.64

ROCE

7.81%

Div. Yield

0.00%

EPS(TTM)

1.03

Turnover

0.57

EV/EBITDA

25.01

Net Margin

0.00%

Op. Margin

0.00%

ROA

0.58%

Quick Ratio

0.00

Curr. Ratio

3.66

Based on fundamentals, this stock's

Performance

Excellent

Health.Global outperforming all market indices

Valuation

Overvalued

Health.Global appears overvalued compared to its peers

Earnings

Good

Health.Global revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Apollo Hospitals	1,27,682.00	63.76	13.48	20.48%	0.32	17.27%	692.92	0.23%	0.70	103.81
Max Healthcare	1,05,470.00	64.89	8.71	14.33%	0.08	13.72%	10.47	0.21%	0.28	7.37
Fortis Healthcare	71,260.50	57.58	6.06	11.31%	0.22	13.36%	6.50	0.13%	0.16	3.05
Aster DM Healthcare	68,387.10	160.00	14.92	8.48%	0.31	10.10%	53.53	0.23%	0.46	5.20
Narayana Hrudayalaya	40,457.30	50.20	8.92	17.76%	0.76	11.42%	127.10	0.23%	0.85	24.77
Global Health	36,944.30	66.67	9.33	14.05%	0.06	15.26%	149.24	0.04%	0.77	18.46
KRISHNA INST OF MED SCI L	32,838.20	135.74	8.76	10.74%	0.63	7.99%	93.54	0.00%	0.46	6.52
Dr. Lal Path Labs	28,275.50	43.61	8.78	21.78%	0.07	27.45%	8.90	1.56%	1.01	30.45
Poly Medicure	16,538.80	51.57	5.32	10.37%	0.08	12.71%	301.18	0.21%	0.53	33.15
Syngene International	16,265.80	49.65	3.25	7.78%	0.05	9.52%	3.34	0.32%	0.67	7.58

Healthcare Global Enterprises Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹2,218.14	₹1,907.87	₹1,691.41	₹1,394.78
Other Income	₹39.53	₹21.19	₹16.22	₹15.67
Total Revenue	₹2,257.66	₹1,929.06	₹1,707.63	₹1,410.45
Total Expenses	₹2,201.47	₹1,865.63	₹1,662.73	₹1,415.86
Profit Before Tax	₹56.96	₹67.73	₹44.88	₹87.77
Tax	₹8.13	₹26.40	₹27.25	₹48.85
Profit After Tax	₹48.83	₹41.33	₹17.63	₹38.93
EPS - Basic	₹3.19	₹3.46	₹2.11	₹4.14
EPS - Diluted	₹3.14	₹3.43	₹2.10	₹3.97

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹56.96	₹67.73	₹44.88	₹87.77
Income before WC changes	₹425.49	₹359.14	₹320.17	₹254.35
Change in Assets	-₹110.54	-₹39.69	-₹104.21	-₹57.50
Change in Liabilities	₹34.05	₹12.50	₹58.34	₹46.98
Change in WC	-₹76.50	-₹27.19	-₹45.87	-₹10.52
Cash flow from Operations	₹317.11	₹284.58	₹251.59	₹220.12
Cash flow from Investing	-₹487.75	-₹225.73	-₹133.03	₹124.59
Cash flow from Financing	-₹42.44	-₹64.02	-₹140.07	-₹154.89
Total Cash Flow	-₹213.08	-₹5.16	-₹21.51	₹189.83
Cash (Start of the year)	₹166.02	₹171.18	₹192.69	₹2.87
Cash (End of the year)	-₹47.06	₹166.02	₹171.18	₹192.69

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹2,699.44	₹2,027.65	₹1,735.68	₹1,717.19
Current Assets	₹843.80	₹679.85	₹580.34	₹502.34
Total Assets	₹3,543.24	₹2,707.50	₹2,316.02	₹2,219.52
Current Liabilities	₹1,046.42	₹743.71	₹570.32	₹469.74
Net Current Asset	-₹202.62	-₹63.85	₹10.02	₹32.59
Non-Current Liabilities	₹1,506.77	₹1,098.68	₹876.28	₹866.07
Equity Capital	₹990.05	₹865.12	₹869.42	₹883.71
Total Equity & Liabilities	₹3,543.24	₹2,707.50	₹2,316.02	₹2,219.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹1,276.52	₹1,099.29	₹1,005.57	₹849.83
Other Income	₹38.58	₹16.88	₹10.82	₹12.42
Total Revenue	₹1,315.10	₹1,116.17	₹1,016.39	₹862.25
Total Expenses	₹1,260.70	₹1,045.21	₹955.77	₹834.12
Profit Before Tax	₹19.58	₹54.87	₹57.62	₹81.04
Tax	₹16.05	₹20.91	₹17.43	₹42.79
Profit After Tax	₹3.53	₹33.96	₹40.19	₹38.25
EPS - Basic	₹0.25	₹2.44	₹2.89	₹2.95
EPS - Diluted	₹0.25	₹2.42	₹2.88	₹2.83

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹19.58	₹53.70	₹57.62	₹81.04
Income before WC changes	₹246.15	₹227.52	₹208.12	₹160.13
Change in Assets	-₹103.94	₹10.37	-₹77.14	-₹41.01
Change in Liabilities	₹22.30	₹4.12	₹16.67	₹20.00
Change in WC	-₹81.64	₹14.49	-₹60.47	-₹21.02
Cash flow from Operations	₹145.95	₹208.89	₹130.40	₹124.40
Cash flow from Investing	-₹347.32	-₹253.94	-₹137.70	₹48.65
Cash flow from Financing	-₹41.55	₹95.92	-₹41.71	-₹41.04
Total Cash Flow	-₹242.92	₹50.87	-₹49.02	₹132.00
Cash (Start of the year)	₹121.18	₹70.31	₹119.33	-₹12.68
Cash (End of the year)	-₹121.75	₹121.18	₹70.31	₹119.33

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹1,963.35	₹1,674.82	₹1,357.19	₹1,287.46
Current Assets	₹640.45	₹513.07	₹372.52	₹356.16
Total Assets	₹2,603.80	₹2,187.89	₹1,729.71	₹1,643.62
Current Liabilities	₹622.84	₹373.44	₹220.80	₹215.08
Net Current Asset	₹17.61	₹139.63	₹151.72	₹141.07
Non-Current Liabilities	₹789.64	₹625.87	₹363.79	₹330.84
Equity Capital	₹1,191.32	₹1,188.59	₹1,145.12	₹1,097.69
Total Equity & Liabilities	₹2,603.80	₹2,187.89	₹1,729.71	₹1,643.62

* All values are in INR Crore

Qty

Bid

1399

666.55

Ask

Qty

Bid Total: 1399

Ask Total: 0

Buy orders: 100%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Neutral

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

58.45

Neutral

ATR (14)

22.21

Neutral

STOCH(9,6)

61.64

Neutral

STOCH RSI (14)

39.21

Neutral

ADX(9)

20.69

Bearish

UO(9)

48.31

Neutral

ROC(12)

3.44

Bullish

WillR(14)

-29.47

Neutral

Period

Simple value

Exponential vaue

662.33

665.2

10D

665.02

661.12

20D

649.9

652.99

50D

639.39

636.18

100D

602.08

628.17

About Healthcare Global Enterprises

ISIN

INE075I01017

Sector Market Cap

₹ 9,992.8 Cr

HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company offers cancer care, fertility treatment, advanced screening and diagnostic services, and tertiary care. It operates a cancer care network in India in terms of the total number of private cancer treatment centers under the brand HCG. The Company provides fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. The Triesta brand offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company operates a comprehensive cancer care center in Indore, Madhya Pradesh. It is also engaged in the radiation business in Indore, Madhya Pradesh. Its multispecialty hospitals deliver tertiary care for cardiac, bone and joint, brain, and spine.

Healthcare Global Enterprises Financial Highlights

Revenue: Healthcare Global Enterprises reported revenue of ₹2,570.40 crore in FY26 vs ₹2,257.66 crore in FY25. It showed an increase of 13.85% on a yearly basis.
Operating Profit: Healthcare Global Enterprises reported an operating profit of ₹26.92 crore in FY26 vs ₹56.96 crore in FY25. It showed a decrease of 52.74% on a year-on-year basis.
Net Profit: Healthcare Global Enterprises reported a net profit of ₹22.78 crore in FY26 vs ₹48.83 crore in FY25. It showed a decrease of 53.35% on a yearly basis.

Healthcare Global Enterprises Quarterly Result Highlights

Healthcare Global Enterprises reported revenue of ₹665.40 crore in Mar 2026, compared with ₹635.54 crore in Dec 2025, representing an increase of 4.70% on a quarter-on-quarter (QoQ) basis.
Healthcare Global Enterprises reported an operating profit of ₹1.25 crore in Mar 2026, compared with ₹6.07 crore in Dec 2025, representing an increase of 120.59% on a quarter-on-quarter (QoQ) basis.
Healthcare Global Enterprises reported a profit of ₹4.04 crore in Mar 2026, compared with ₹7.90 crore in Dec 2025, reflecting an increase of 151.14% on a QoQ basis.
The earnings per share (EPS) of Healthcare Global Enterprises stood at ₹3.19 during Mar 2026.